Michael E. Neufeld

Michael E. Neufeld

Auto-generated profile, based on publicly available information

Michael E. Neufeld

Department of Orthopaedics, University of British Columbia, Vancouver, British Columbia, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MNMichael E. Neufeld
Michael E. Neufeld
BLBrent A. Lanting
Brent A. Lanting
MSMichael Shehata
Michael Shehata
JHJames L. Howard
James L. Howard
SMSteven J. MacDonald
Steven J. MacDonald
EVEdward M. Vasarhelyi
Edward M. Vasarhelyi
Background: The prevalence and outcomes of unexpected positive cultures (UPCs) of specimens taken during presumed aseptic revision total hip arthroplasty (THA) are unclear. The purpose of this study was to determine the prevalence of UPC and infection-free implant survival in this patient population. Secondary aims included identifying factors associated with subsequent infection-related failure in patients with UPC. Methods: We reviewed all THA revisions (n = 2,288) performed at our institution from 2006 to 2019. Presumed aseptic revision THAs with intraoperative culture(s) were eligible (n = 1,196), and those with UPC were included in a Kaplan-Meier analysis to determine the infection-free implant survival and in Cox regression analysis to identify factors associated with infection-related failure. Results: UPC(s) were documented for 9.2% (110) of 1,196 aseptic THA revisions. The 2- and 5-year infection-free implant survival in the entire UPC cohort was 93.1% (95% confidence interval [CI] = 90.5% to 95.7%) and 86.8% (95% CI = 82.9% to 90.7%), respectively. The 2- and 5-year infection-free survival with failure due to infection with the same microorganism as identified in the UPC as the end point was 95.8% (95% CI = 93.7% to 97.9%) and 94.3% (95% CI = 91.7% to 96.9%), respectively. Subsequent infection-related failures caused by the same microorganism as identified in the UPC were more likely to occur after revisions with ≥2 UPCs than after those with 1 UPC (p = 0.024). Revision due to adverse metal reaction was a risk factor for subsequent infection-related failure (hazard ratio [HR] = 14.49, 95% CI = 2.69 to 78.04). Patients with a single UPC who were not treated with antibiotics had no subsequent periprosthetic joint infections (PJIs) caused by the same microorganism as identified in the UPC. Conclusions: The prevalence of UPC was 9.2%, and the infection-free implant survival in patients with UPC is encouraging. Implant survival free of PJI caused by the same microorganism as identified in the UPC was excellent. Aseptic revision for adverse metal reaction was a risk factor for subsequent PJI in patients with UPC. No patient with a single UPC who was not treated with antibiotics developed PJI caused by the UPC-identified microorganism, suggesting that in the absence of other signs of infection a single UPC does not warrant antibiotic treatment. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

1 January 2023 in The Bone & Joint Journal
Verified
Journal Article
Closed access
BFBas L. Fransen
Bas L. Fransen
FBFrancisco J. Bengoa
Francisco J. Bengoa
MNMichael E. Neufeld
Michael E. Neufeld
GSGerard A. Sheridan
Gerard A. Sheridan
DGDonald S. Garbuz
Donald S. Garbuz
LHLisa C. Howard
Lisa C. Howard
Aims: Several short- and mid-term studies have shown minimal liner wear of highly cross-linked polyethylene (HXLPE) in total hip arthroplasty (THA), but the safety of using thinner HXLPE liners to maximize femoral head size remains uncertain. The objective of this study was to analyze clinical survival and radiological wear rates of patients with HXLPE liners, a 36 mm femoral head, and a small acetabular component with a minimum of ten years’ follow-up. Methods: We retrospectively identified 55 patients who underwent primary THA performed at a single centre, using HXLPE liners with 36 mm cobalt-chrome heads in acetabular components with an outer diameter of 52 mm or smaller. Patient demographic details, implant details, death, and all-cause revisions were recorded. Cox regression and Kaplan-Meier survival was used to determine all-cause and liner-specific revision. Of these 55 patients, 22 had a minimum radiological follow-up of seven years and were assessed radiologically for linear and volumetric wear. Results: Overall survival rate for all-cause revision was 94.5% (95% confidence interval (CI) 81.7% to 97.2%) at a mean follow-up of 12.8 years (10.9 to 18.7). Three patients were revised, none for liner wear, fracture, or dissociation. A total of 22 patients were included in the radiological analysis (mean follow-up 9.9 years (7.5 to 13.7)). Mean linear liner wear was 0.085 mm (95% CI -0.086 to 0.257) and the volumetric wear rate was 11.097 mm3/year (95% CI -6.5 to 28.7). Conclusion: Using HXLPE liners with 36 mm heads in 52 mm acetabular components or smaller is safe, with excellent survival and low rates of linear and volumetric wear at medium-term follow-up. Patients did not require revision surgery for liner complications such as fracture, dissociation, or wear. Our results suggest that the advantages of using larger heads outweigh the potential risks of using thin HXLPE liners. Cite this article: Bone Joint J 2023;105-B(1):29–34.

1 March 2022 in The Bone & Joint Journal
Verified
Journal Article
Closed access
MNMichael E. Neufeld
Michael E. Neufeld
ELEmanuel Francis Liechti
Emanuel Francis Liechti
FSFernando Soto
Fernando Soto
PLPhilip Linke
Philip Linke
SBSophia-Marlene Busch
Sophia-Marlene Busch
MCMustafa Citak
Mustafa Citak
Aims: The outcome of repeat septic revision after a failed one-stage exchange for periprosthetic joint infection (PJI) in total knee arthroplasty (TKA) remains unknown. The aim of this study was to report the infection-free and all-cause revision-free survival of repeat septic revision after a failed one-stage exchange, and to determine whether the Musculoskeletal Infection Society (MSIS) stage is associated with subsequent infection-related failure. Methods: We retrospectively reviewed all repeat septic revision TKAs which were undertaken after a failed one-stage exchange between 2004 and 2017. A total of 33 repeat septic revisions (29 one-stage and four two-stage) met the inclusion criteria. The mean follow-up from repeat septic revision was 68.2 months (8.0 months to 16.1 years). The proportion of patients who had a subsequent infection-related failure and all-cause revision was reported and Kaplan-Meier survival for these endpoints was determined. Patients were categorized according to the MSIS staging system, and the association with subsequent infection was analyzed. Results: At the most recent follow-up, 17 repeat septic revisions (52%) had a subsequent infection-related failure and the five-year infection-free survival was 59% (95% confidence interval (CI) 39 to 74). A total of 19 underwent a subsequent all-cause revision (58%) and the five-year all-cause revision-free survival was 47% (95% CI 28 to 64). The most common indication for the first subsequent aseptic revision was loosening. The MSIS stage of the host status (p = 0.663) and limb status (p = 1.000) were not significantly associated with subsequent infection-related failure. Conclusion: Repeat septic revision after a failed one-stage exchange TKA for PJI is associated with a high rate of subsequent infection-related failure and all-cause revision. Patients should be counselled appropriately to manage expectations. The host and limb status according to the MSIS staging system were not associated with subsequent infection-related failure. Cite this article: Bone Joint J 2022;104-B(3):386–393.

1 January 2022 in The Bone & Joint Journal
Verified
Journal Article
Closed access
ELEmanuel Francis Liechti
Emanuel Francis Liechti
MNMichael E. Neufeld
Michael E. Neufeld
FSFernando Soto
Fernando Soto
PLPhilip Linke
Philip Linke
SBSophia-Marlene Busch
Sophia-Marlene Busch
MCMustafa Citak
Mustafa Citak
The British Editorial Society of Bone & Joint Surgery

19 May 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MNMichael E. Neufeld
Michael E. Neufeld
BLBrent A. Lanting
Brent A. Lanting
MSMichael Shehata
Michael Shehata
DNDouglas D.R. Naudie
Douglas D.R. Naudie
RMRichard W. McCalden
Richard W. McCalden
EVEdward M. Vasarhelyi
Edward M. Vasarhelyi

1 July 2024 in JBJS Reviews
Verified
Journal Article
Closed access
YAYasir AlShehri
Yasir AlShehri
PMPanayiotis D. Megaloikonomos
Panayiotis D. Megaloikonomos
MNMichael E. Neufeld
Michael E. Neufeld
LHLisa C. Howard
Lisa C. Howard
NGNelson V. Greidanus
Nelson V. Greidanus
BMBassam A. Masri
Bassam A. Masri
Update: This article was updated on August 23, 2024, because of a previous error. On page 1, the following footnote was omitted but has since been included: *Yasir AlShehri, MD, and Panayiotis D. Megaloikonomos, MD, contributed equally to this work as first authors. An erratum has been published: JBJS Rev. 2024;12(7):e24.00064ER. » The demographic profile of candidates for total knee arthroplasty (TKA) is shifting toward younger and more active individuals. » While cemented fixation remains the gold standard in TKA, the interest is growing in exploring cementless fixation as a potentially more durable alternative. » Advances in manufacturing technologies are enhancing the prospects for superior long-term biological fixation. » Current research indicates that intermediate to long-term outcomes of modern cementless TKA designs are comparable with traditional cemented designs. » The selection of appropriate patients is critical to the success of cementless fixation techniques in TKA. » There is a need for high-quality research to better understand the potential differences and relative benefits of cemented vs. cementless TKA systems.